In the last trading session, 3.37 million ProPhase Labs Inc (NASDAQ:PRPH) shares changed hands as the company’s beta touched -0.41. With the company’s per share price at $0.39 changed hands at $0.0 or -1.98% during last session, the market valuation stood at $16.21M. PRPH’s last price was a discount, traded about -1297.44% off its 52-week high of $5.45. The share price had its 52-week low at $0.22, which suggests the last value was 43.59% up since then.
Analysts gave the ProPhase Labs Inc (PRPH) stock a consensus recommendation rating of Hold, calculated at a mean rating of 1.00. If we narrow down to specifics, the data shows that 0 out of 1 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 1 recommended PRPH as a Hold, 0 felt it is a Buy and 0 rated the stock as Underweight.
ProPhase Labs Inc (NASDAQ:PRPH) trade information
Instantly PRPH was in red as seen at the end of in last trading. With action 27.72%, the performance over the past five days has been green. The company’s shares are showing year-to-date downside of -48.88%, with the 5-day performance at 27.72% in the green. However, in the 30-day time frame, ProPhase Labs Inc (NASDAQ:PRPH) is 38.02% up.
The consensus price target for the stock as assigned by Wall Street analysts is 14, meaning bulls need an upside of 97.21% from its current market value. According to analyst projections, PRPH’s forecast low is 14 with 14 as the target high. To hit the forecast high, the stock’s price needs a -3489.74% plunge from its current level, while the stock would need to soar -3489.74% for it to hit the projected low.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of -57.56%. The 2025 estimates are for ProPhase Labs Inc earnings to increase by 78.54%.
PRPH Dividends
ProPhase Labs Inc is expected to release its next quarterly earnings report in June.
RENAISSANCE TECHNOLOGIES LLC holds the second largest percentage of outstanding shares, with 2.3349% or 0.22 million shares worth $0.92 million as of 2024-06-30.
Among Mutual Funds, the top two as of Dec 31, 2024 were VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund . With 454.64 shares estimated at $0.18 million under it, the former controlled 1.09% of total outstanding shares. On the other hand, VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund held about 0.43% of the shares, roughly 181.39 shares worth around $70198.0.
